(Q34464260)

English

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

lupus erythematosus

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

Gerd-Rüdiger Burmester

14

object named as

Gerd-Rüdiger Burmester

0 references

Andrea Rubbert-Roth

5

object named as

Andrea Rubbert-Roth

0 references

16

object named as

Falk Hiepe

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

13

object named as

Georg Schett

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Andreas Radbruch

15

object named as

Andreas Radbruch

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

object named as

Adriano Taddeo

11

0 references

author name string

Tobias Alexander

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ramona Sarfert

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jens Klotsche

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Anja A Kühl

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Andrea Rubbert-Roth

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hannes-Martin Lorenz

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jürgen Rech

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bimba F Hoyer

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Qingyu Cheng

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Aderajew Waka

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Michael Wiesener

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Reinhard E Voll

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

20 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1474-1478

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Immunopathogenic mechanisms of systemic autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Proteasome inhibitors in multiple myeloma: 10 years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Proteasome inhibitor-based therapy for antibody-mediated rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Long-lived autoreactive plasma cells drive persistent autoimmune inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Organization of immunological memory by bone marrow stroma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

6 July 2018

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

27 October 2018

Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

27 October 2018

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

27 October 2018

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4484251

27 October 2018

Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE

1 reference

https://pubmed.ncbi.nlm.nih.gov/25710470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25710470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ANNRHEUMDIS-2014-206016

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34464260&oldid=2036308216"